by TD Admin | Oct 12, 2020 | Blog Posts
June 2020 A new audio series brought to you by The Focal Therapy Clinic, where our host, Clare Delmar, explores some issues facing men diagnosed with prostate cancer that are little known, less understood and almost never talked about. Read the full...
by TD Admin | Oct 12, 2020 | Blog Posts
September 2020 Consultant Urologist Tim Dudderidge discusses the stages in the imaging-led prostate cancer diagnostic pathway, and outlines what patients need to know. Read the full story
by TD Admin | Aug 21, 2019 | Blog Posts
Bladder cancer is the sixth most commonly diagnosed cancer in the European Union. Here, we evaluate the performance of a novel, commercially available enzyme-linked immunosorbent assay utilising MCM5 antibodies (ADXBLADDER; Arquer Diagnostics Ltd, Sunderland, UK) for...
by Tim Dudderidge | Apr 3, 2019 | Blog Posts
The FORECAST study has been assessing men with recurrent prostate cancer after prior radiotherapy. The study looked at the diagnosis / staging process to see whether a combination of MRI, PET-CT, Whole Body MRI and Bone scan could improve the detection of metastatic...
by Tim Dudderidge | Apr 3, 2019 | Blog Posts
The INDEX study has now completed recruitment. Its a landmark study in the making with the largest series of focal prostate HIFU treatments ever studied. Men with cancer on one side of the prostate who elected to have focal prostate HIFU have been studied and results...
by Tim Dudderidge | Apr 3, 2019 | Blog Posts
During my time as a Lecturer at UCL researching cancer markers I investigated the role of the cell-cycle protein Mcm5 in the field of urological cancer diagnosis. Since then the technology has been commercialised by Arquer diagnostics Ltd and I have led trials in both...
